Követés
Ali Saber Abdelhameed
Ali Saber Abdelhameed
Professor, College of Pharmacy, King Saud University
E-mail megerősítve itt: ksu.edu.sa
Cím
Hivatkozott rá
Hivatkozott rá
Év
Ascorbic acid inhibits human insulin aggregation and protects against amyloid induced cytotoxicity
P Alam, AZ Beg, MK Siddiqi, SK Chaturvedi, RK Rajpoot, MR Ajmal, ...
Archives of biochemistry and biophysics 621, 54-62, 2017
1262017
Structure of amyloid oligomers and their mechanisms of toxicities: Targeting amyloid oligomers using novel therapeutic approaches
P Salahuddin, MT Fatima, AS Abdelhameed, S Nusrat, RH Khan
European journal of medicinal chemistry 114, 41-58, 2016
1132016
Interplay of multiple interaction forces: Binding of tyrosine kinase inhibitor nintedanib with human serum albumin
P Alam, AS Abdelhameed, RK Rajpoot, RH Khan
Journal of Photochemistry and Photobiology B: Biology 157, 70-76, 2016
1022016
A novel global hydrodynamic analysis of the molecular flexibility of the dietary fibre polysaccharide konjac glucomannan
MS Kök, AS Abdelhameed, S Ang, GA Morris, SE Harding
Food Hydrocolloids 23 (7), 1910-1917, 2009
962009
A comprehensive spectroscopic and computational investigation to probe the interaction of antineoplastic drug nordihydroguaiaretic acid with serum albumins
S Nusrat, MK Siddiqi, M Zaman, N Zaidi, MR Ajmal, P Alam, A Qadeer, ...
PLoS One 11 (7), e0158833, 2016
912016
Investigating the site selective binding of busulfan to human serum albumin: Biophysical and molecular docking approaches
M Siddiqi, S Nusrat, P Alam, S Malik, SK Chaturvedi, MR Ajmal, ...
International journal of biological macromolecules 107, 1414-1421, 2018
862018
Fluorescence spectroscopic and molecular docking studies of the binding interaction between the new anaplastic lymphoma kinase inhibitor crizotinib and bovine serum albumin
AS Abdelhameed, AM Alanazi, AH Bakheit, HW Darwish, HA Ghabbour, ...
Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 171, 174-182, 2017
812017
Interaction of new kinase inhibitors cabozantinib and tofacitinib with human serum alpha-1 acid glycoprotein. A comprehensive spectroscopic and molecular Docking approach
MR Ajmal, AS Abdelhameed, P Alam, RH Khan
Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 159, 199-208, 2016
792016
Binding of Janus kinase inhibitor tofacitinib with human serum albumin: multi-technique approach
AS Abdelhameed, P Alam, RH Khan
Journal of Biomolecular Structure and Dynamics 34 (9), 2037-2044, 2016
712016
Probing the interaction of cephalosporin antibiotic–ceftazidime with human serum albumin: A biophysical investigation
MK Siddiqi, P Alam, SK Chaturvedi, S Nusrat, MR Ajmal, ...
International journal of biological macromolecules 105, 292-299, 2017
592017
Isatin-benzoazine molecular hybrids as potential antiproliferative agents: synthesis and in vitro pharmacological profiling
HA Abdel-Aziz, WM Eldehna, AB Keeton, GA Piazza, AA Kadi, MW Attwa, ...
Drug Design, Development and Therapy, 2333-2346, 2017
582017
Nanosuspension: an emerging trend for bioavailability enhancement of etodolac
SA Afifi, MA Hassan, AS Abdelhameed, KA Elkhodairy
International journal of polymer science 2015 (1), 938594, 2015
582015
Extended Fujita approach to the molecular weight distribution of polysaccharides and other polymeric systems
SE Harding, P Schuck, AS Abdelhameed, G Adams, MS Kök, GA Morris
Methods 54 (1), 136-144, 2011
562011
Design, synthesis and in vitro anticancer evaluation of a stearic acid-based ester conjugate
AA Khan, AM Alanazi, M Jabeen, A Chauhan, AS Abdelhameed
Anticancer research 33 (6), 2517-2524, 2013
532013
An LC–MS/MS method for rapid and sensitive high‐throughput simultaneous determination of various protein kinase inhibitors in human plasma
AS Abdelhameed, MW Attwa, AA Kadi
Biomedical Chromatography 31 (2), e3793, 2017
492017
Metabolic Stability Assessment of New PARP Inhibitor Talazoparib Using Validated LC–MS/MS Methodology: In silico Metabolic Vulnerability and Toxicity Studies
M Attwa, A Kadi, AS Abdelhameed, H Alhazmi
Drug Design, Development and Therapy 14, 783—793, 2020
462020
A spectroscopic approach to investigate the molecular interactions between the newly approved irreversible ErbB blocker" Afatinib" and bovine serum albumin
AM Alanazi, AS Abdelhameed
PLoS One 11 (1), e0146297, 2016
452016
Polyols (Glycerol and Ethylene glycol) mediated amorphous aggregate inhibition and secondary structure restoration of metalloproteinase-conalbumin (ovotransferrin)
MV Khan, M Ishtikhar, G Rabbani, M Zaman, AS Abdelhameed, RH Khan
International Journal of Biological Macromolecules 94, 290-300, 2017
422017
Reactive Intermediates and Bioactivation Pathways Characterization of Avitinib by LC-MS/MS: In vitro Metabolic Investigation
MW Attwa, AA Kadi, AS Abdelhameed
Journal of Pharmaceutical and Biomedical Analysis 164, 659-667, 2019
402019
A biophysical and computational study unraveling the molecular interaction mechanism of a new Janus kinase inhibitor Tofacitinib with bovine serum albumin
AS Abdelhameed, S Nusrat, MR Ajmal, SM Zakariya, M Zaman, RH Khan
Journal of Molecular Recognition, 2017
402017
A rendszer jelenleg nem tudja elvégezni a műveletet. Próbálkozzon újra később.
Cikkek 1–20